Indication
dermoid
1 clinical trial
2 products
Product
VactosertibClinical trial
A Phase II, Open-Label, Randomized, Controlled Study to Evaluate Efficacy and Safety of Vactosertib and Imatinib Combination in Patients With Advanced Desmoid Tumor (Aggressive Fibromatosis) Compared With Imatinib MonotherapyStatus: Recruiting, Estimated PCD: 2021-11-23
Product
Imatinib